PLESAH Trademark
Trademark Overview
On Thursday, November 16, 2023, a trademark application was filed for PLESAH with the United States Patent and Trademark Office. The USPTO has given the PLESAH trademark a serial number of 98273126. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Tuesday, February 10, 2026. This trademark is owned by Eli Lilly and Company. The PLESAH trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative co...
General Information
| Serial Number | 98273126 |
| Word Mark | PLESAH |
| Filing Date | Thursday, November 16, 2023 |
| Status | 732 - THIRD EXTENSION - GRANTED |
| Status Date | Tuesday, February 10, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 23, 2024 |
Trademark Statements
| Translation of Words in Mark | The wording "PLESAH" has no meaning in a foreign language. |
| Goods and Services | Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, December 22, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Eli Lilly and Company |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Indianapolis, IN 46285
US |
| Party Name | Eli Lilly and Company |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Indianapolis, IN 46285
US |
Trademark Events
| Event Date | Event Description |
| Monday, November 20, 2023 | NEW APPLICATION ENTERED |
| Friday, December 22, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, June 20, 2024 | ASSIGNED TO EXAMINER |
| Thursday, June 20, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, July 3, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, July 23, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, July 23, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 17, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, February 3, 2025 | SOU TEAS EXTENSION RECEIVED |
| Monday, February 3, 2025 | SOU EXTENSION 1 FILED |
| Tuesday, February 4, 2025 | SOU EXTENSION 1 GRANTED |
| Tuesday, February 4, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, August 7, 2025 | SOU TEAS EXTENSION RECEIVED |
| Thursday, August 7, 2025 | SOU EXTENSION 2 FILED |
| Thursday, August 7, 2025 | SOU EXTENSION 2 GRANTED |
| Friday, August 8, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, February 10, 2026 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, February 10, 2026 | SOU EXTENSION 3 FILED |
| Tuesday, February 10, 2026 | SOU EXTENSION 3 GRANTED |
| Wednesday, February 11, 2026 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, May 21, 2026 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, May 21, 2026 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, May 21, 2026 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
